Neuroimaging has revolutionized our understanding of the brain and its role in psychiatric disorders. The Journal of Clinical Psychiatry is at the forefront of this exciting field, offering readers a deep dive into the latest advancements in techniques like MRI, PET, and fMRI. Our expert editors curate content that explores how neuroimaging is shedding light on the neural substrates of disorders like depression, schizophrenia, and anxiety. As we move towards an era of precision psychiatry, neuroimaging stands as a powerful tool, and our journal is committed to keeping clinicians informed about its potential.
Recently published articles about Neuroimaging
Recent JCP Articles on Neuroimaging
Academic Highlights
Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Bipolar Type I Disorder: A Consensus Panel Report
August 13, 2025
A consensus panel reviews treatment considerations in the use of long-acting injectable aripiprazole monohydrate in bipolar type I disorder.
Academic Highlights
Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Schizophrenia: A Consensus Panel Report
August 13, 2025
A consensus panel reviews treatment considerations in the use of long-acting injectable aripiprazole monohydrate in schizophrenia.
Original Research
Effect of Aripiprazole or rTMS Augmentation Versus Switching to Venlafaxine on Quality of Life
August 11, 2025
Augmentation with aripiprazole, but not rTMS, improved quality of life significantly versus venlafaxine XR/duloxetine switch in patients with treatment-resistant depression.
Recent PCC Articles on Neuroimaging
Featured Neuroimaging Research
Original Research
The Characteristics and Burden of Cognitive Impairments in Schizophrenia in the US
August 11, 2025
Medical Expenditure Panel Survey data showed that over half of adults with schizophrenia report cognitive impairments, which were associated with higher healthcare costs and lower quality of life.